NO991208L - FremgangsmÕte for rensing av apolipoproteiner og et preparat for anvendelse ved fremgangsmÕten - Google Patents

FremgangsmÕte for rensing av apolipoproteiner og et preparat for anvendelse ved fremgangsmÕten

Info

Publication number
NO991208L
NO991208L NO991208A NO991208A NO991208L NO 991208 L NO991208 L NO 991208L NO 991208 A NO991208 A NO 991208A NO 991208 A NO991208 A NO 991208A NO 991208 L NO991208 L NO 991208L
Authority
NO
Norway
Prior art keywords
polymeric material
surfactant
hydrophobic
amphiphilic compound
atherosclerosis
Prior art date
Application number
NO991208A
Other languages
English (en)
Other versions
NO991208D0 (no
NO323217B1 (no
Inventor
Hans Ageland
M Lena Nystr
Josefine Persson
Folke Tjerneld
Original Assignee
Pharmacia & Upjohn Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE9603304A external-priority patent/SE9603304D0/xx
Application filed by Pharmacia & Upjohn Ab filed Critical Pharmacia & Upjohn Ab
Publication of NO991208D0 publication Critical patent/NO991208D0/no
Publication of NO991208L publication Critical patent/NO991208L/no
Publication of NO323217B1 publication Critical patent/NO323217B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/775Apolipopeptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO19991208A 1996-09-11 1999-03-11 Fremgangsmate for rensing av apolipoprotein A eller apolipoprotein E. NO323217B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9603304A SE9603304D0 (sv) 1996-09-11 1996-09-11 Process for purifying a compound
US2673996P 1996-09-26 1996-09-26
PCT/SE1997/001502 WO1998011127A1 (en) 1996-09-11 1997-09-08 A process for purifying apolipoproteins and a composition for use in the process

Publications (3)

Publication Number Publication Date
NO991208D0 NO991208D0 (no) 1999-03-11
NO991208L true NO991208L (no) 1999-05-11
NO323217B1 NO323217B1 (no) 2007-01-29

Family

ID=26662746

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19991208A NO323217B1 (no) 1996-09-11 1999-03-11 Fremgangsmate for rensing av apolipoprotein A eller apolipoprotein E.

Country Status (12)

Country Link
EP (1) EP0954524B1 (no)
JP (1) JP2001500154A (no)
AT (1) ATE236925T1 (no)
AU (1) AU729536B2 (no)
CA (1) CA2265929A1 (no)
DE (1) DE69720786T2 (no)
DK (1) DK0954524T3 (no)
ES (1) ES2197361T3 (no)
NO (1) NO323217B1 (no)
NZ (1) NZ334589A (no)
PT (1) PT954524E (no)
WO (1) WO1998011127A1 (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7205280B2 (en) * 1998-03-11 2007-04-17 Cognosci, Inc. Methods of suppressing microglial activation
ATE266672T1 (de) * 1998-12-30 2004-05-15 Folke Tjerneld Trennungsmethode unter verwendung von flüssig- flüssig partition
SE9904803D0 (sv) * 1999-12-27 1999-12-27 Amersham Pharm Biotech Ab Method for the isolation of hydrophobic proteins
FR2827192B1 (fr) * 2001-07-13 2004-06-04 Cognis France Sa Preparations contenant des agents tensio-actifs non ioniques comme agents d'extraction
CN100357325C (zh) * 2005-10-23 2007-12-26 王贤理 一种抗apoA I、apoB抗体制备方法以及用于检测apoA I、apoB的试剂盒
WO2012024691A1 (en) 2010-08-20 2012-02-23 President And Fellows Of Harvard College Multiphase systems for analysis of solid materials

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1229996B (it) * 1989-04-20 1991-09-20 Cesare Sirtori Espressione di apolipoproteina ai e apolipoproteina ai-milano in lievito e composizioni farmaceutiche che contengono dette apolipoproteine.
WO1993000443A1 (en) * 1991-06-26 1993-01-07 Bio-Technology General Corp. Purification of recombinant apolipoprotein e from bacteria

Also Published As

Publication number Publication date
DK0954524T3 (da) 2003-08-04
DE69720786T2 (de) 2003-11-06
NZ334589A (en) 2000-07-28
NO991208D0 (no) 1999-03-11
ES2197361T3 (es) 2004-01-01
NO323217B1 (no) 2007-01-29
AU4143097A (en) 1998-04-02
EP0954524A1 (en) 1999-11-10
DE69720786D1 (de) 2003-05-15
CA2265929A1 (en) 1998-03-19
PT954524E (pt) 2003-08-29
JP2001500154A (ja) 2001-01-09
EP0954524B1 (en) 2003-04-09
WO1998011127A1 (en) 1998-03-19
ATE236925T1 (de) 2003-04-15
AU729536B2 (en) 2001-02-01

Similar Documents

Publication Publication Date Title
SE9603303D0 (sv) Process for purifying a protein
SE9603304D0 (sv) Process for purifying a compound
CA1253668A (en) Method of separation of sugars and concentrated sulfuric acid
ATE452870T1 (de) (meth)acrylsaeurekristall und verfahren zur herstellung und aufreinigung von waessriger (meth)acrylsaeure
EP1132365A4 (en) AZEOTROPIC MIXTURE OF 1,1,1,3,3-PENTAFLUORO-PROPANE AND 1,1,1-TRIFLUORO-3-CHLORO-2-PROPENE, A METHOD FOR THE SEPARATION AND CLEANING OF THE SAME, AND A METHOD FOR THE PRODUCTION OF 1,1,1,3 , 3-PENTAFLUOROPROPAN AND 1,1,1-TRIFLUORO-3-CHLORO-PROPENE
DE60142449D1 (de) Verfahren zur herstellung von furfural, essigsäure und ameisensäure aus verbrauchter zellstoffkochlauge
SE9603068D0 (sv) Process for purifying a protein
KR890014439A (ko) 지방산의 연속적인 에스테르화 방법
DE69427357D1 (de) Verfahren zur herstellung von zusammensetzungen zur reinigung von halbleiterverfahrensgasen zur entfernung von lewis-säure und oxydationsmittelverunreinigungen
RU2005136662A (ru) Способ очистки сырой терефталевой кислоты в зоне последующего окисления путем введения водяного пара
BR9407655A (pt) Método para a produçao de steres cíclicos T
DE60001173D1 (de) Verfahren zum extrahieren und reinigung von paclitaxel aus natürlicher quelle
FI102962B1 (fi) Menetelmä ksylitolin valmistamiseksi
ATE284855T1 (de) Verfahren zur trennung von 1,3-propandiol oder glycerin oder eine mischung davon aus einer biologischen mischung
NO991208D0 (no) FremgangsmÕte for rensing av apolipoproteiner og et preparat for anvendelse ved fremgangsmÕten
ATE323777T1 (de) Verfahren zur herstellung von lysophosphatidyl- ethanolamin
DE69805799D1 (de) Behandlung von formaldehyd enthaltenden gemischen
DE69820580D1 (de) Verfahren zur Abtrennung von Metallen durch micellare Ultrafiltration, geeignet zur Behandlung von radioaktiven Abfallstoffen
DE69738397D1 (de) Verfahren zur aufreinigung von apolipoprotein-a oder apolipoprotein-e aus menschlichem plasma
ATE79116T1 (de) Aminosaeureester, verfahren zu ihrer herstellung und ihre verwendung.
SE8204273D0 (sv) Forfarande for rening av beta-sitosterol isolerad fran neutralemnet i sulfatcellulosaprocessens rasapa
NZ515158A (en) Process for the purification of sterols from hydrocarbon extracts using evaporative fractionation
ATE212983T1 (de) Verfahren zur herstellung von 5-chlorcarbonyl-5h- dibenz/b,f/azepin
ATE395428T1 (de) Verfahren zur isolierung und reinigung von lipidezellwandkomponenten
ATE302178T1 (de) Verfahren zur herstellung von spezifikationsgerechtem phthalsäureanhydrid